These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 1091740

  • 1. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM, Germain RN, Benacerraf B.
    J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
    [Abstract] [Full Text] [Related]

  • 2. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC, Prager MD.
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [Abstract] [Full Text] [Related]

  • 3. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN, Williams RM, Benacerraf B.
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [Abstract] [Full Text] [Related]

  • 4. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E, Bonavida B.
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [Abstract] [Full Text] [Related]

  • 5. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H, Fujiwara H, Takai Y, Izumi Y, Sano S, Tsuchida T, Hamaoka T.
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [Abstract] [Full Text] [Related]

  • 6. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN, Williams RM, Benacerraf B.
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [Abstract] [Full Text] [Related]

  • 7. Cellular cooperation during in vivo anti-hapten antibody responses. III. The helper cell activity of activated thymocytes, of spleen cells treated with anti-theta serum, and of spleen cells from anti-thymocyte serum-treated or adult thymectomized donors.
    Janeway CA.
    J Immunol; 1975 Apr; 114(4):1408-14. PubMed ID: 1078836
    [Abstract] [Full Text] [Related]

  • 8. Allograft cytotoxicity. Two populations of effector cell detectable by cytolytic and cytostatic assays in vitro.
    Jones B, Jones TC, Roitt IM.
    Immunology; 1977 Apr; 32(4):591-9. PubMed ID: 415967
    [Abstract] [Full Text] [Related]

  • 9. In vitro studies of the rabbit immune system. VI. Rabbit anti-mouse cytotoxic T effector cells are inhibited by anti-rabbit T cell serum in the absence of complement.
    Redelman D, Trefts PE.
    J Immunol; 1978 Oct; 121(4):1532-9. PubMed ID: 308967
    [Abstract] [Full Text] [Related]

  • 10. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ, Taramelli D, Holden HT, Varesio L.
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [Abstract] [Full Text] [Related]

  • 11. Effector mechanism of tumor immunity in murine plasmacytoma.
    Chen YH, Anderson AB.
    Cancer Res; 1988 Mar 15; 48(6):1398-403. PubMed ID: 3257896
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic effects of antigen- and mitogen-induced T cells on various targets.
    Bevan MJ, Cohn M.
    J Immunol; 1975 Feb 15; 114(2 Pt 1):559-65. PubMed ID: 123541
    [Abstract] [Full Text] [Related]

  • 13. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC.
    J Immunol; 1985 Jul 15; 135(1):53-62. PubMed ID: 3158707
    [Abstract] [Full Text] [Related]

  • 14. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.
    Evans R, Duffy T.
    J Immunol; 1985 Jun 15; 134(6):4255-60. PubMed ID: 3872913
    [Abstract] [Full Text] [Related]

  • 15. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW, Whitten HD, Skurzak HM, Andersson B, Lidin B.
    J Immunol; 1975 Nov 15; 115(5):1288-94. PubMed ID: 1080777
    [Abstract] [Full Text] [Related]

  • 16. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD.
    Cancer Res; 1986 Apr 15; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [Abstract] [Full Text] [Related]

  • 17. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E, Mokyr MB.
    Cancer Res; 1988 Sep 01; 48(17):4834-42. PubMed ID: 3261626
    [Abstract] [Full Text] [Related]

  • 18. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI, Taraban VY, Seledtsova GV, Samarin DM, Avdeev IV, Senyukov VV, Kozlov VA.
    Cell Immunol; 1997 Nov 25; 182(1):12-9. PubMed ID: 9427805
    [Abstract] [Full Text] [Related]

  • 19. Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.
    Eggers AE, Wunderlich JR.
    J Immunol; 1975 May 25; 114(5):1554-6. PubMed ID: 123545
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.
    Greenberg AH, Shen L, Medley G.
    Immunology; 1975 Oct 25; 29(4):719-29. PubMed ID: 810417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.